Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
160 Results for "
Transforming growth factor beta
" in MedChemExpress (MCE) Product Catalog:
Products (160)
160 Results for "Transforming growth factor beta" in MCE Product Catalog:
170
170 Publications Verification
Cat. No.: HY-P7118
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Human
Source:
CHO
69
69 Cited Publications
Cat. No.: HY-P7117
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Rat;Mouse
Source:
HEK293
57
57 Cited Publications
Cat. No.: HY-P70543
Purity: ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Human
Source:
HEK293
31
31 Cited Publications
Cat. No.: HY-P70648
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Rat;Mouse
Source:
HEK293
22
22 Cited Publications
Synonyms: E-616452; SJN 2511
Target:
Research Areas:
RepSox (E-616452) is a potent and selective transforming growth factor-beta receptor I/activin like kinase 5 (TGF-β-RI/ALK5) inhibitor. RepSox inhibits ALK5 autophosphorylation with an IC50 value of 4 nM. RepSox can be used for the research of obesity and associated metabolic diseases such as type 2 diabetes .
20
20 Cited Publications
Target:
Research Areas:
SB 525334 is a potent and selective transforming growth factor β1 receptor (ALK5) inhibitor with an IC50 of 14.3 nM.
19
Target:
Research Areas:
19
Target:
Research Areas:
13
13 Cited Publications
Cat. No.: HY-P7119
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB2; Transforming growth factor, beta 2; Transforming growth factor beta 2; BSC-1 Cell growth Inhibitor; Glioblastoma-Derived T-Cell Suppressor factor; TGF-beta2; Transforming growth factor beta-2 Proprotein; Polyergin; Prepro-Transforming growth factor
Species:
Human
Source:
HEK293
8
8 Cited Publications
Cat. No.: HY-P7120
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB3; Transforming growth factor, beta 3; Prev. ARVD1; Transforming growth factor beta; Prev. ARVD; TGF-beta3; Transforming growth factor beta-3 Proprotein; LDS5; Prepro-Transforming growth factor beta-3; RNHF; Arrhythmogenic Right Ventricular Dysplasia
Species:
Human
Source:
HEK293
7
7 Cited Publications
Cat. No.: HY-P78168
Purity: ≥ 90%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Human
Source:
HEK293
5
Target:
Research Areas:
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
4
3
3 Cited Publications
Target:
Research Areas:
SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway. BMPs are members of the transforming growth factor beta (TGFβ) family of secreted signaling molecules.
3
3 Cited Publications
Cat. No.: HY-P78360
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Mouse
Source:
HEK293
3
3 Cited Publications
Cat. No.: HY-P78213
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Human
Source:
HEK293
3
3 Cited Publications
Cat. No.: HY-P78668
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming growth factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor beta-1;
Species:
Human
Source:
HEK293
3
3 Cited Publications
Synonyms: Antibiotic A 15104 Y; PClP
Target:
Research Areas:
Pentachloropseudilin (Antibiotic A 15104 Y; PClP) is a reversible and allosteric potent inhibitor of Myo1s (class 1 myosins) with IC50s range from 1 to 5 μM for mammalian class-1 myosins and greater than 90 μM for class-2 and class-5 myosins. Pentachloropseudilin is a potent inhibitor of transforming growth factor-β (TGF-β)-stimulated signaling, with an IC50 of 0.1 to 0.2 μM for TGF-β .
2
2 Cited Publications
Cat. No.: HY-78349
CAS No.: 607737-87-1
Target:
Research Areas:
A 77-01 is a potent inhibitor of transforming growth factor (TGF)-β type I receptor superfamily activin-like kinase ALK5 with an IC50 of 25 nM .
2
2 Cited Publications
Cat. No.: HY-P70649
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB2; Transforming growth factor, beta 2; Transforming growth factor beta 2; BSC-1 Cell growth Inhibitor; Glioblastoma-Derived T-Cell Suppressor factor; TGF-beta2; Transforming growth factor beta-2 Proprotein; Polyergin; Prepro-Transforming growth factor beta-2; CAEND2; Cetermin; LDS4; G-TSF
Species:
Rat;Mouse
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
